Proving the Business Case for the Internet of Things

Philips device monitors patients during transit

Steve Rogerson
July 5, 2017



Philips has introduced a device that provides portable, uninterrupted patient monitoring during in-hospital transport and at the bedside.
 
The IntelliVue X3 provides an intuitive smart-phone-style operation that is said to enable quickly and easily continuous monitoring during transport for the most critical patients.
 
When patients are transferred from one department to another, clinicians often struggle with incomplete data records leading to inefficiency due to multiple systems operating independently. Getting a complete view into patient data to allow for informed clinical decision support requires manual steps and can contribute to a higher potential for error, especially when dealing with critical care patients.
 
IntelliVue X3 integrates seamlessly into the existing IntelliVue patient monitoring system, including bedside and transport monitors, the clinical network and the Dutch company’s family of central stations. Data from the IntelliVue X3 are also integrated into mobile applications, the hospital network and interfaces that connect the system to other medical devices and to the hospital’s electronic medical record (EMR) system.
 
As part of this larger patient monitoring portfolio, X3 can help clinicians provide better care for patients across all levels of acuity and supporting institution-wide standardisation.
 
“The challenge of delivering care efficiently and effectively within hospitals’ acute environments continues to increase,” said Felix Baader, business leader at Philips. “Health systems need accurate and transparent information and processes to help clinical staff make faster, more consistent decisions based on patient conditions and history. With the development of the IntelliVue X3, we’re aiming to ensure that data are not being lost during transitions and that we’re able to better equip clinicians with the information they need, when they need it.”
 
In addition to providing complete data records, it provides a comprehensive and scalable set of clinical measurements, ranging from basic to advanced monitoring. It allows for advanced monitoring during stationary and transport situations, including dual invasive blood pressure, built in mainstream CO2, a choice between three SpO2 technologies, and ECG and arrhythmia.
 
The IntelliVue X3 has received the CE Mark in Europe and is pending 510(k) and is thus not yet available for sale in the USA.